Dermatology

Latest News

FDA Approves Dupixent as First Targeted Treatment for Bullous Pemphigoid in Adults
FDA Approves Dupixent as First Targeted Treatment for Bullous Pemphigoid in Adults

June 20th 2025

This approval marks the eighth disease indication for Dupixent as a new alternative for patients—many of whom are elderly and have limited treatment options.

Teens With Hidradenitis Suppurativa Face Higher Risk of Chronic Health and Mental Health Conditions
Teens With Hidradenitis Suppurativa Face Higher Risk of Chronic Health and Mental Health Conditions

June 16th 2025

GPT-4 AI Model Outperforms Traditional Tools in Predicting Cutaneous Squamous Cell Carcinoma Outcomes
GPT-4 AI Model Outperforms Traditional Tools in Predicting Cutaneous Squamous Cell Carcinoma Outcomes

June 11th 2025

A New Combination Therapy Looks Promising for Treating Adult Vitiligo
A New Combination Therapy Looks Promising for Treating Adult Vitiligo

June 5th 2025

Study Links Semaglutide to Rare Skin Pain Condition
Study Links Semaglutide to Rare Skin Pain Condition

May 14th 2025

Video Interviews

More News

© 2025 MJH Life Sciences

All rights reserved.